Nandala Srinivas

Title: Nandala Srinivas: Innovator in Pharmaceutical Chemistry

Introduction

Nandala Srinivas is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for key pharmaceutical compounds. His work has implications for the production of important medications.

Latest Patents

Nandala Srinivas holds a patent for a process related to fingolimod hydrochloride. This patent describes a method for the preparation of diethyl 2-acetamido-2-(4-octyl phenyl)ethyl malonate, which is a crucial intermediate in the synthesis of fingolimod hydrochloride. The process involves the reaction of 2-(4-octylphenyl)ethyl iodide with diethyl acetamido malonate in the presence of a base and an iodinating agent, conducted in an organic solvent. The resulting compound meets regulatory standards for impurities, ensuring its suitability for pharmaceutical applications.

Career Highlights

Nandala Srinivas is currently employed at Emcure Pharmaceuticals Limited, where he continues to innovate in the pharmaceutical sector. His expertise in chemical processes has contributed to the advancement of drug development within the company.

Collaborations

He has collaborated with notable colleagues, including Mukund Keshav Gurjar and Narendra Kumar Tripathy. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Nandala Srinivas is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in drug synthesis. His contributions, particularly in the area of fingolimod hydrochloride, highlight the importance of innovation in the pharmaceutical industry.